Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-17-006256

Options or other derivatives

  • President & CEO acquired 11,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PIMSTONE SIMON N. · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-10-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +11,000 $3.10 2027-10-22 11,000 11,000 D
Loading xslF345X03/formfour.xml…